Who actually holds the CCAP shares related to this Form 4?

The reported CCAP shares are held by Fidelity & Guaranty Life Insurance Company of New York, which is a wholly owned subsidiary of Fidelity & Guaranty Life Insurance Company, the reporting person on the Form 4.

Crescent Capital holder sells 59K shares at $10.60

Q: How many CCAP shares were sold on each date in this filing?

On August 26, 2026, the reporting person sold 32,091 shares of CCAP common stock. On August 27, 2026, it sold an additional 27,195 shares, for a total of 59,286 shares sold over the two days.

Q: How many CCAP shares did the insider hold after these transactions?

The Form 4 does not state a specific post-transaction share balance for the reporting person; the relevant fields for total shares following the transactions are left blank in this filing.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. (CCAP) reported that Fidelity & Guaranty Life Insurance Company, a ten percent owner, sold a total of 59,286 shares of common stock in two open-market transactions on August 26 and 27, 2026, at volume-weighted average prices around $10.60 per share. The filing notes these trades were made under a Rule 10b5-1 trading plan, and some shares are held through Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.

Insider Trade Summary 10b5-1

Net Seller: 59,286 shares

Net Sell 2 txns

Insider FIDELITY & GUARANTY LIFE INSURANCE CO

Role 10% Owner

Sold 59,286 shs ($629K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F3, F2}	27,195	$10.6043	$288K
Sale	Common Stock ^{F1, F2}	32,091	$10.6013	$340K

Holdings After Transaction: Common Stock — 4,072,564 shares (Direct)

Footnotes (3)

F1. The shares were sold in multiple transactions at prices ranging from $10.60 to $10.625 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2. Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.
F3. The shares were sold in multiple transactions at prices ranging from $10.60 to $10.67 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold August 26, 2026: 32,091 shares of Common Stock Volume-weighted average price August 26, 2026: $10.6013 per share Shares sold August 27, 2026: 27,195 shares of Common Stock +2 more

5 metrics

Shares sold August 26, 2026 32,091 shares of Common Stock Open-market sale by Fidelity & Guaranty Life Insurance Company

Volume-weighted average price August 26, 2026 $10.6013 per share Multiple trades ranging from $10.60 to $10.625

Shares sold August 27, 2026 27,195 shares of Common Stock Open-market sale by Fidelity & Guaranty Life Insurance Company

Volume-weighted average price August 27, 2026 $10.6043 per share Multiple trades ranging from $10.60 to $10.67

Total shares sold 59,286 shares of Common Stock Aggregate of two sale transactions reported in this Form 4

Key Terms

Rule 10b5-1 trading plan, volume weighted average price, ten percent owner

3 terms

Rule 10b5-1 trading plan regulatory

"The filing’s 10b5-1 box indicates trades under a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

volume weighted average price financial

"The price reported reflects the volume weighted average price for the transactions"

The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

ten percent owner regulatory

"Fidelity & Guaranty Life Insurance Co is reported as a ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did CCAP disclose in this Form 4?

CCAP disclosed that Fidelity & Guaranty Life Insurance Company, a ten percent owner, sold an aggregate of 59,286 shares of Crescent Capital BDC common stock in open-market transactions on August 26–27, 2026.

How many CCAP shares were sold on each date in this filing?

On August 26, 2026, the reporting person sold 32,091 shares of CCAP common stock. On August 27, 2026, it sold an additional 27,195 shares, for a total of 59,286 shares sold over the two days.

At what prices were the CCAP shares sold in this Form 4?

The sales occurred in multiple trades. On August 26, 2026, shares were sold at prices ranging from $10.60 to $10.625, with a volume-weighted average price of $10.6013. On August 27, 2026, trades ranged from $10.60 to $10.67, with a volume-weighted average price of $10.6043.

Were the CCAP insider sales made under a Rule 10b5-1 trading plan?

Yes. The Form 4 indicates that the trades were effected under a Rule 10b5-1 trading plan, as shown by the checked 10b5-1 box, meaning they followed a pre-established trading arrangement.

How many CCAP shares did the insider hold after these transactions?

The Form 4 does not state a specific post-transaction share balance for the reporting person; the relevant fields for total shares following the transactions are left blank in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/28/2026 - 03:02 PM EDT Accepted by SEC EDGAR 08/28/2026 - 03:01 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FIDELITY & GUARANTY LIFE INSURANCE CO

(Last)

(First)

(Middle)

801 GRAND AVENUE, SUITE 2600

(Street)

DES MOINES

IOWA

50309

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crescent Capital BDC, Inc. [ CCAP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/26/2026		S		32,091	D	$10.6013⁽¹⁾	4,099,759⁽²⁾	D
Common Stock	08/27/2026		S		27,195	D	$10.6043⁽³⁾	4,072,564⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares were sold in multiple transactions at prices ranging from $10.60 to $10.625 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

2. Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

3. The shares were sold in multiple transactions at prices ranging from $10.60 to $10.67 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	Tessa Cantonwine, Secretary	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR